美国 · 股市与财经 · Bloomberg

Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials

来源：Bloomberg · 美国 4 小时前

Bambusa Therapeutics Inc. filed for a initial public offering to help fund trials of its drugs to treat eczema and other inflammation disorders.

在 Bloomberg 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.bloomberg.com)

推荐阅读

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

Business Insider

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

Big Controversy Upends a Contest About Microscopic Videos

Why Record Crude Output Can’t Solve America’s Diesel Crisis